EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of COVID‐19 on Respiratory Virus Infections in Children, Japan, 2018–2023

Emi Takashita iD, Kohei Shimizu, Chiharu Kawakami, Tomoko Momoki, Miwako Saikusa, Hiroki Ozawa, Makoto Kumazaki, Shuzo Usuku, Nobuko Tanaka, Ryuichi Senda, Ichiro Okubo, Seiichiro Fujisaki und 9 weitere

Immunity, Inflammation and Disease · 2025

DOI: 10.1002/iid3.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Emi Takashita und 20 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, Respiratory Tract Infections, Virus Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by Ministry of Health, Labor and Welfare (21HA2003) and Japan Society for the Promotion of Science (JP18K10036)., Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID‐19, caused by SARS‐CoV‐2, was first documented in Japan in January 2020. We previously reported an increased risk of rhinovirus infections among children during the early phase of the COVID‐19 pandemic. Here, we assessed the impact of COVID‐19 on respiratory virus infections after SARS‐CoV‐2 spread nationwide.

Methods

We analyzed clinical specimens from 4012 patients with respiratory infections in Yokohama, Japan from January 2018 to April 2023.

Results

Among 15 representative respiratory viruses we detected (influenza virus, rhinovirus, coxsackievirus, echovirus, enterovirus, human coronavirus 229E, HKU1, NL63, and OC43, human metapneumovirus, human parainfluenza virus, human parechovirus, RSV, human adenovirus, human bocavirus, human parvovirus B19, herpes simplex virus type 1, and varicella‐zoster virus), influenza was most affected by the COVID‐19 pandemic, with no influenza viruses detected for nearly 3 years.

Conclusions

The decrease in influenza infections following the emergence of SARS‐CoV‐2 may have contributed to the previously reported increase in rhinovirus infections. The rhinovirus outbreak, rather than SARS‐CoV‐2, may have contributed to the decrease in enveloped virus infections (RSV, parainfluenza viruses, metapneumovirus, and coronavirus 229E, HKU1, NL63, and OC43), possibly due to negative virus‐virus interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory Tract InfectionsVirus DiseasesHumansJapanChildChild, PreschoolInfantSARS-CoV-2MaleAdolescentFemaleInfluenza, Human

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2influenzarespiratory syncytial virusrhinovirusviral interference

Autor:innen und Institutionen

  • Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
  • Yokohama City Institute of Public Health, Kanagawa, Japan.
  • Pandemic Preparedness, Infection, and Advanced Research Center, The University of Tokyo, Tokyo, Japan.
  • Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.

ORCID-Profile: Emi Takashita, Mina Nakauchi

Förderung

  • This study was supported by Ministry of Health, Labor and Welfare (21HA2003) and Japan Society for the Promotion of Science (JP18K10036).
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Takashita, E., Shimizu, K., Kawakami, C., Momoki, T., Saikusa, M., Ozawa, H., Kumazaki, M., Usuku, S., Tanaka, N., Senda, R., Okubo, I., Fujisaki, S., Nagata, S., Morita, H., Miura, H., Watanabe, K., Nakauchi, M., Matsuzaki, Y., Watanabe, S., …, & Kawaoka, Y. (2025). Impact of COVID‐19 on Respiratory Virus Infections in Children, Japan, 2018–2023. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70176

Vancouver

Takashita E, Shimizu K, Kawakami C, Momoki T, Saikusa M, Ozawa H, et al. Impact of COVID‐19 on Respiratory Virus Infections in Children, Japan, 2018–2023. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70176

BibTeX
@article{Takashita2025,
  author = {Takashita, Emi and Shimizu, Kohei and Kawakami, Chiharu and Momoki, Tomoko and Saikusa, Miwako and Ozawa, Hiroki and Kumazaki, Makoto and Usuku, Shuzo and Tanaka, Nobuko and Senda, Ryuichi and Okubo, Ichiro and Fujisaki, Seiichiro and Nagata, Shiho and Morita, Hiroko and Miura, Hideka and Watanabe, Kayo and Nakauchi, Mina and Matsuzaki, Yoko and Watanabe, Shinji and Hasegawa, Hideki and Kawaoka, Yoshihiro},
  title = {Impact of COVID‐19 on Respiratory Virus Infections in Children, Japan, 2018–2023},
  journal = {Immunity, Inflammation and Disease},
  year = {2025},
  doi = {10.1002/iid3.70176}
}
Kostenlos starten →